Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TERESITA D SANTIAGO-ESCALERA

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1245542570
CMS profile
147932
Location
WESTBURY, NY

General Payments · PY2018–2024

$1,727.73

  • Reported across 62 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$381.53

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $362.26 12
Education $19.27 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Sumitomo Pharma America, Inc. $142.90 1
Astellas Pharma US Inc $67.78 4
PFIZER INC. $45.91 2
SHIELD THERAPEUTICS INC $41.86 2
Biogen, Inc. $28.36 1
ABBVIE INC. $19.78 1
Agile Therapeutics, Inc. $18.01 1
Evofem Biosciences, Inc. $16.93 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $321.40 13
PY2019 $315.76 9
PY2020 $25.52 2
PY2021 $153.90 8
PY2022 $70.59 4
PY2023 $459.03 13
PY2024 $381.53 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.78 07/23/2024 Food and Beverage Undisputed 01/23/2026 1106017937 CMS
Agile Therapeutics, Inc. $18.01 01/28/2024 Food and Beverage Undisputed 01/23/2026 1154842517 CMS
Astellas Pharma US Inc $16.85 01/22/2024 Food and Beverage Undisputed 01/23/2026 1139294658 CMS
Astellas Pharma US Inc $19.58 04/16/2024 Food and Beverage Undisputed 01/23/2026 1139321486 CMS
Astellas Pharma US Inc $16.20 06/03/2024 Food and Beverage Undisputed 01/23/2026 1139351721 CMS
Astellas Pharma US Inc $15.15 09/30/2024 Food and Beverage Undisputed 01/23/2026 1139411729 CMS
Biogen, Inc. $28.36 04/04/2024 Food and Beverage Undisputed 01/23/2026 1104808217 CMS
Evofem Biosciences, Inc. $16.93 01/24/2024 Food and Beverage Undisputed 01/23/2026 1091284086 CMS
PFIZER INC. $19.27 02/07/2024 Education Undisputed 01/23/2026 1131453716 CMS
PFIZER INC. $26.64 02/26/2024 Food and Beverage Undisputed 01/23/2026 1131446646 CMS
SHIELD THERAPEUTICS INC $20.02 04/08/2024 Food and Beverage Undisputed 01/23/2026 1150126667 CMS
SHIELD THERAPEUTICS INC $21.84 10/02/2024 Food and Beverage Undisputed 01/23/2026 1150148117 CMS
Sumitomo Pharma America, Inc. $142.90 09/27/2024 Food and Beverage Undisputed 01/23/2026 1148914582 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.